Superhydrophilic and Superamphiphilic Coatings

Olveira, Sandro; Stojanović, Ana; Seeger, Stefan

doi:10.1002/9781118883051.ch3

Cited by 7 publications

(3 citation statements)

References 128 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with PAH, mental disorders had a negative impact on quality of life, irrespective of severity of disease (21,58,121). Similar findings were described in bronchiectasis, with anxiety and depression symptoms predicting a significantly worse quality of life (23,26). In interstitial lung disease, the quality of life measure impact depressive symptoms (122), and the presence of depression is significantly correlated with dyspnoea symptoms and sleep quality (123).…”

Section: Effect On Quality Of Lifementioning

confidence: 85%

“…In PAH, the prevalence of depressive symptoms ranged from 15.9% to 55.1 (21,22,58), while anxiety was between 28% and 45 % (21,58), showing a strong association with the level of functional limitation (22) and quality of life (58). For patients with bronchiectasis, 20% to 34% had elevated depression-related scores and 38% to 55% had elevated anxiety-related scores (23,24,26), also showing significant association with poor quality of life questionnaire scores (26).…”

Section: Prevalence Of Anxiety and Depression As Comorbidities In Chrmentioning

confidence: 92%

“…For asthma, estimates for major depression among persons with asthma varied from 2% to 26% across the surveys, with prevalence generally between 5-10% (19). For idiopathic pulmonary fibrosis (IPF), pulmonary arterial hypertension (PAH) and bronchiectasis, the prevalence of depression or anxiety have been observed to be in the range of 20% to 50% (20)(21)(22)(23)(24)(25)(26). In all groups, the concomitant presence of psychological comorbidities had a negative impact on quality of life (21,23,(26)(27)(28)(29)(30).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Pumar¹

View full text Add to dashboard Cite

Background: Anxiety and depression are psychological conditions that are highly prevalent among patients with chronic lung disease. These conditions are associated with increased morbidity and, in certain groups, increased mortality. Cognitive behaviour therapy (CBT) has shown potential as a treatment of anxiety and depression among patients with COPD, asthma and bronchiectasis. Pulmonary rehabilitation has the strongest evidence regarding its benefit in these patients, mainly through improved physical capacity and education. Consequently, the combination of both treatments (CBT and pulmonary rehabilitation) is promising, with potentially enhanced therapeutic benefits. The primary aim of this thesis was to determine the impact of cognitive behavioural therapy (CBT) as a treatment for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. The study also assessed risk factors for the presence of anxiety and depression in patients attending pulmonary rehabilitation, the effect of CBT on quality of life and, through a subgroup analysis, the impact of mild cognitive impairment on CBT.Methods: A parallel group, randomised controlled trial (RCT) was conducted, with longitudinal follow-up of 12 months. Participants were screened from the pulmonary rehabilitation program at The Prince Charles Hospital and recruited if they had Geriatric Depression Scale (GDS) ≥4/15 or Geriatric Anxiety Inventory (GAI) ≥3/20, suggestive of depression or anxiety, respectively. In addition to pulmonary rehabilitation, the Intervention group received CBT comprised by two face-to-face sessions and 4 phone sessions, while the Control group received usual care. The main outcome measures were GDS and GAI; secondary outcomes were St. Georges Respiratory Questionnaire (SGRQ), pulmonary rehabilitation attendance and 6 minute walk test (6MWT). Results:The majority of patients attending pulmonary rehabilitation had COPD (58.5%), with the remainder having asthma (19.7%), interstitial lung disease (ILD) (9%) and bronchiectasis (12.4%). Of the patients screened, 25 (13%) had only symptoms of anxiety, 33 (17%) of only depression and 62 (32%) had symptoms of both anxiety and depression. Anxiety and depression were strongly correlated with SGRQ (p<0.01) and pulmonary rehabilitation program attendance. GDS scores were also correlated with 6MWT (p<0.01), past smoking (p<0.01), body-mass index (p<0.01), and body-mass index, airflow obstruction, dyspnea, and exercise capacity index (BODE) scores (p<0.01); while GAI was not correlated with other parameters. 65 patients were randomised to the study (24 in the Intervention group, 41 in the Control group). Of the 24 patients in the Intervention group, 10 (42%) failed to attend pulmonary rehabilitation or withdrew from the study. In the Intervention group, GDS significantly improved, compared to baseline, at the end of rehabilitation (mean difference -3.1, 95% CI -4.39 to -1.7; P<0.01), 3 months follow-up (mean difference -1.46, 95% CI -4.17 to -0.75; P<0.01) and 12 m...

show abstract

Section: Effect On Quality Of Lifementioning

confidence: 85%

Section: Prevalence Of Anxiety and Depression As Comorbidities In Chrmentioning

confidence: 92%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Pumar¹

View full text Add to dashboard Cite

show abstract

Paints and Polymers

Weimer

Wright

Hodgins

2020

Handbook of Trace Evidence Analysis

View full text Add to dashboard Cite

Ultrafast epitaxial growth of CuO nanowires using atmospheric pressure plasma with enhanced electrocatalytic and photocatalytic activities

et al. 2021

View full text Add to dashboard Cite

This work reports an environment friendly alternative to epitaxially grow copper oxide nanowires (NWs) on copper substrates using single step atmospheric pressure plasma jet assisted oxidation. NWs of average length 300 nm are grown rapidly in 5 minutes along with transforming the surface to superhydrophilic. This method introduces defects in the nanowire structure which is otherwise difficult to achieve due to the highly isotropic nature of nanowire growth. High resolution transmission electron microscopy reveals vacancies and structural defects such as lattice twinning and kinks. Theoretical investigations using density functional theory calculations indicated that oxygen vacancies reduces the adsorption energy of methanol molecules onto the CuO (111) surface and shifts the Fermi level towards conduction band. During electrocatalysis, these defect-rich nanowires exhibit twice the catalytic activity toward oxygen evolution reaction (OER) and methanol oxidation reaction (MOR) in comparison to the traditionally thermally grown nanowires. Moreover, retreating the electrodes after each stability test drops the contact resistance similar to the prisitine sample. Additionally, these NW photocathodes demonstrate an exceptional photocurrent of 2.2 mAcm -2 and have an excellent degradation activity towards organic pollutants namely phenol and paracetamol. This facile growth method can be used to engineer nanowires of other transition metals with enhanced activities.

show abstract

Superhydrophilic and Superamphiphilic Coatings

Cited by 7 publications

References 128 publications

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Paints and Polymers

Ultrafast epitaxial growth of CuO nanowires using atmospheric pressure plasma with enhanced electrocatalytic and photocatalytic activities

Contact Info

Product

Resources

About